Ignite Creation Date:
2024-05-06 @ 6:16 PM
Last Modification Date:
2024-10-26 @ 2:44 PM
Study NCT ID:
NCT05600920
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2022-10-27
Brief Title:
A Single-arm Dose-escalation Trial of Long-acting Recombinant Human IL-7 NT-I7 Efineptakin Alfa for Idiopathic CD4 Lymphopenia
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-18
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-27
First Submit QC Date:
October 31 2022
Study First Post Date:
2022-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED